These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 8243498)
1. Aspects of schizandrin metabolism in vitro and in vivo. Cui YY; Wang MZ Eur J Drug Metab Pharmacokinet; 1993; 18(2):155-60. PubMed ID: 8243498 [TBL] [Abstract][Full Text] [Related]
2. [Metabolic transformation of schizandrin]. Cui YY; Wang MZ Yao Xue Xue Bao; 1992; 27(1):57-63. PubMed ID: 1529716 [TBL] [Abstract][Full Text] [Related]
3. [Enzyme kinetics of schizandrin metabolism and sex differences in rat liver microsomes]. Xu MJ; Wang GJ; Xie HT; Huang Q; Jia YW Yao Xue Xue Bao; 2007 Jul; 42(7):730-4. PubMed ID: 17882956 [TBL] [Abstract][Full Text] [Related]
4. CYP3A catalyses schizandrin biotransformation in human, minipig and rat liver microsomes. Cao YF; Zhang YY; Li J; Ge GB; Hu D; Liu HX; Huang T; Wang YC; Fang ZZ; Sun DX; Huo H; Yin J; Yang L Xenobiotica; 2010 Jan; 40(1):38-47. PubMed ID: 20001672 [TBL] [Abstract][Full Text] [Related]
5. Chemical-pharmacokinetic-pharmacodynamic fingerprints of Schisandra chinensis alcoholic extract. Wang BL; Hu JP; Sheng L; Chen H; Li Y Yao Xue Xue Bao; 2013 May; 48(5):734-40. PubMed ID: 23888698 [TBL] [Abstract][Full Text] [Related]
6. Studies on antihepatitic drugs. Total synthesis of (+/-)schizandrin C and its analogs. Xie JX; Zhou J; Zhang CZ; Yang JH; Chen JX Sci Sin B; 1983 Dec; 26(12):1291-303. PubMed ID: 6673110 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of Schizandrin and Its Pharmaceutical Products Assessed Using a Validated LC-MS/MS Method. Li CL; Cheng YY; Hsieh CH; Tsai TH Molecules; 2018 Jan; 23(1):. PubMed ID: 29342955 [No Abstract] [Full Text] [Related]
8. Pharmacokinetic comparisons of schizandrin after oral administration of schizandrin monomer, Fructus Schisandrae aqueous extract and Sheng-Mai-San to rats. Xu M; Wang G; Xie H; Huang Q; Wang W; Jia Y J Ethnopharmacol; 2008 Feb; 115(3):483-8. PubMed ID: 18060709 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and distribution of schisandrol A and its major metabolites in rats. Liu X; Cong L; Wang C; Li H; Zhang C; Guan X; Liu P; Xie Y; Chen J; Sun J Xenobiotica; 2019 Mar; 49(3):322-331. PubMed ID: 29251086 [TBL] [Abstract][Full Text] [Related]
10. Structure determination of biliary metabolites of schizandrin in rat and dog. Ikeya Y; Sugama K; Tanaka M; Wakamatsu T; Ono H; Takeda S; Oyama T; Maruno M Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):121-9. PubMed ID: 7895304 [TBL] [Abstract][Full Text] [Related]
11. Bioanalytical assay development and validation for simultaneous quantification of five schisandra lignans in rat primary hepatocytes based on LC-MS/MS: application to a real-time uptake study for Schisandra Lignan Extract. Kang D; Shao Y; Yin X; Xiao J; Rao T; Shen B; Chen H; Zhu Z; Wang G; Liang Y Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27459903 [TBL] [Abstract][Full Text] [Related]
12. Determination of schizandrin in rat plasma by high-performance liquid chromatography-mass spectrometry and its application in rat pharmacokinetic studies. Xu M; Wang G; Xie H; Wang R; Wang W; Li X; Li H; Zhu D; Yue L J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 828(1-2):55-61. PubMed ID: 16236562 [TBL] [Abstract][Full Text] [Related]
13. The in vitro metabolism of norcotinine and related biotransformation products by microsomal preparations. Eldirdiri N; Ulgen M; Jacob P; Gorrod JW Eur J Drug Metab Pharmacokinet; 1997; 22(4):385-90. PubMed ID: 9512938 [TBL] [Abstract][Full Text] [Related]
14. Interaction of deoxyschizandrin and schizandrin B with liver uptake transporters OATP1B1 and OATP1B3. Lu Y; Hu Q; Chen L; Zhang H; Huang S; Xiong Y; Xia C Xenobiotica; 2019 Feb; 49(2):239-246. PubMed ID: 29405807 [TBL] [Abstract][Full Text] [Related]
15. [Study on the chemical constituents of the fruit handles from Schizandra chinensis]. Shi L; He XX; Pan Y; Han L; Yang XO; Zhao YQ Zhong Yao Cai; 2009 Jul; 32(7):1054-6. PubMed ID: 19873730 [TBL] [Abstract][Full Text] [Related]
16. Production of deoxyschizandrin and γ-schizandrin in shoot-differentiating and undifferentiating callus cultures of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine). Szopa A; Ekiert H J Biotechnol; 2013 Jun; 165(3-4):209-13. PubMed ID: 23562619 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and liver uptake of three Schisandra lignans in rats after oral administration of liposome encapsulating β-cyclodextrin inclusion compound of Schisandra extract. Ding Z; Xiao J; Zhang Y; Jiang Y; Chen W; Hu J; Guo Y; Zhang B J Liposome Res; 2019 Jun; 29(2):121-132. PubMed ID: 30821573 [TBL] [Abstract][Full Text] [Related]
18. [Metabolic transformation of (-)-clausenamide in rat liver microsomes]. Yao Q; Wang M Yao Xue Xue Bao; 1998; 33(4):296-9. PubMed ID: 11939071 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of Dibenzo[a,c]cyclooctene derivatives isolated from Fructus Schizandrae Chinensis III. Inhibitory effects on carbon tetrachloride-induced lipid peroxidation, metabolism and covalent binding of carbon tetrachloride to lipids. Liu KT; Lesca P Chem Biol Interact; 1982 Jul; 41(1):39-47. PubMed ID: 7094143 [TBL] [Abstract][Full Text] [Related]
20. Metabolism of 4-(3-cyclohexylpropionyl)-1-(2-ethoxyphenyl) piperazine (D-16120) by rat liver microsomes. Caputo O; Rocco F; Grosa G Eur J Drug Metab Pharmacokinet; 1994; 19(4):303-10. PubMed ID: 7737231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]